- Home
- OMEX vs ATRA Comparison
OMEX vs ATRA Comparison
Compare OMEX & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OMEX | ATRA |
|---|---|---|
| Founded | 1986 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.8M | 129.4M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | OMEX | ATRA |
|---|---|---|
| Price | $2.24 | $17.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | ★ 848.5K | 74.4K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.97 |
| Revenue | $467,122.00 | ★ $151,930,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.79 |
| Revenue Growth | N/A | ★ 51.27 |
| 52 Week Low | $0.27 | $5.01 |
| 52 Week High | $4.43 | $18.95 |
Technical Indicators
Market Signals| Indicator | OMEX | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 48.14 | 57.89 |
| Support Level | $2.17 | $16.51 |
| Resistance Level | $2.36 | $18.95 |
| Average True Range (ATR) | 0.19 | 1.37 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 18.37 | 59.80 |
Price Performance
Historical ComparisonAbout OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodules (battery metals) projects. Its projects include the ExO Phosphate project, CIC, Ocean Minerals, and the LIHIR Gold project.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).